HealthQuill Guillain-Barre Syndrome
Neurological conditions affect 3.4 billion people or 43% globally, making them the top contributor to the global disease burden ahead of cardiovascular diseases, according to an analysis.
Drugs Health Pharma

Neurological conditions top global cause of disease burden

HQ Team March 18, 2023: Neurological conditions affect 3.4 billion people or 43% globally, making them the top contributor to the global disease.

Read More
The number of sequences to detect the presence of the Covid-19 viral genome, being shared with WHO, has dropped by more than 90%, and the number of countries sharing them has fallen by a third.
Drugs Health Pharma

Global study uncovers subtle health risks linked to Covid-19 vaccines

HQ Team February 28, 2024: An international team of researchers conducted a large study on the safety of COVID-19 vaccines and found potential.

Read More
Day-biter Aedes mosquito takes center stage in Zika infection.
Climate Health Pharma

Opinion: Day-biter Aedes mosquito takes center stage in Zika infection

By Dr K. Leelamoni November 14, 2023: At a district court in the south Indian state of Kerala, on October 30, judges, lawyers.

Read More